Skip to main content

Table 2 Risk factors for poor survival and loss to follow-up during the first year of cART, hazard ratios (HR), univariate and multivariate analysis

From: Improved antiretroviral treatment outcome in a rural African setting is associated with cART initiation at higher CD4 cell counts and better general health condition

Characteristics

 

Univariate analysis

Multivariate analysis§

  

HR

95% CI

p-value

HR#

95% CI

p-value

Age, per 10 years older

0.98

0.87-1.09

0.669

0.97

0.80-1.17

0.760

Female

 

0.77

0.62-0.97

0.025

0.77

0.52-1.15

0.201

Weight, per 10 kg increase

 

0.61

0.54-0.69

<0.001

0.63

0.51-0.76

<0.001

Tuberculosis

Absent

1*

-

-

1*

-

-

 

Suspected

0.49

0.37-0.68

<0.001

0.63

0.44-1.10

0.082

 

Confirmed

0.73

0.45-1.16

0.180

1.28

0.70-2.33

0.421

CD4 cell count

>100

1*

-

-

1*

-

-

 

50-100

1.50

1.07-2.11

0.018

1.37

0.82-2.29

0.230

 

<50

2.31

1.77-3.04

<0.001

1.77

1.15-2.72

0.009

cART

Nevirapine-based

1*

-

-

1*

-

-

 

Efavirenz-based

1.13

0.71-1.79

0.607

0.91

0.54-1.52

0.712

  1. # adjusted for all variables listed in the table
  2. * reference category
  3. § Global test of proportional hazards assumption (Schoenfeld): p = 0.248